EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.
01 1Euroapi France
02 1Hovione FarmaCiencia SA
01 1Korea Mundipharma Co., Ltd.
02 1Synex Co., Ltd.
01 2Micronized fluticasone propionate
01 1France
02 1Portugal
EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.
Micronized fluticasone propionate
Registrant Name : Korea Mundipharma Co., Ltd.
Registration Date : 2024-05-31
Registration Number : 20240531-209-J-1652
Manufacturer Name : Euroapi France
Manufacturer Address : 4 Lieu Dit La Paterie, Vertolaye, 63480, France
Micronized fluticasone propionate
Registrant Name : Synex Co., Ltd.
Registration Date : 2021-03-25
Registration Number : 20210325-209-J-917
Manufacturer Name : Hovione FarmaCiencia SA
Manufacturer Address : Sete Casas, Loures, 2674-506 Portugal
A Flixotide Inhaler manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Flixotide Inhaler, including repackagers and relabelers. The FDA regulates Flixotide Inhaler manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Flixotide Inhaler API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Flixotide Inhaler manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Flixotide Inhaler supplier is an individual or a company that provides Flixotide Inhaler active pharmaceutical ingredient (API) or Flixotide Inhaler finished formulations upon request. The Flixotide Inhaler suppliers may include Flixotide Inhaler API manufacturers, exporters, distributors and traders.
click here to find a list of Flixotide Inhaler suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Flixotide Inhaler Drug Master File in Korea (Flixotide Inhaler KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Flixotide Inhaler. The MFDS reviews the Flixotide Inhaler KDMF as part of the drug registration process and uses the information provided in the Flixotide Inhaler KDMF to evaluate the safety and efficacy of the drug.
After submitting a Flixotide Inhaler KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Flixotide Inhaler API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Flixotide Inhaler suppliers with KDMF on PharmaCompass.
LOOKING FOR A SUPPLIER?
